Nicholas Barker
Nick Barker obtained his PhD from Reading University, UK in 1996. Together with Professor Hans Clevers, he identified dysregulated Wnt signaling as the initiating event in colon cancer. In 2001, he joined Semaia Pharmaceuticals to develop colon cancer therapeutics, then returned to Hans Clevers’ group as a Senior Staff Scientist in 2006, where he identified Lgr5 as a marker of various adult stem cell populations and intestinal Lgr5 stem cells as a cell-of-origin of colon cancer. Moving to Singapore in 2010, he joined A*STAR’s Institute of Medical Biology (IMB) as a Senior Principal Investigator and now holds the position of Research Director. His research focuses on Lgr5 gastric stem cells in self-renewal and cancer. In 2017, he received the NRF Investigatorship and was recognized as a Web of Science Highly Cited Researcher. He is also an Adjunct Professor at NTU, Singapore, and a Research Professor at Kanazawa University, Japan.
Abstracts this author is presenting:
